Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,710 | N/A | 26,310 | 51,820 | 1,010 |
| Marketable Securities | 35,350 | N/A | 14,740 | 10,940 | 82,750 |
| Receivables | 8,670 | N/A | 4,980 | 5,580 | 2,580 |
| Inventories | 1,070 | N/A | 1,770 | 3,330 | 1,050 |
| Other current assets | 13,040 | 13,290 | 8,310 | 5,100 | 4,590 |
| TOTAL | $66,840 | $13,290 | $56,110 | $76,770 | $91,980 |
| Non-Current Assets | |||||
| PPE Net | 24,750 | N/A | 35,140 | 25,700 | 22,310 |
| Other Non-Current Assets | 2,690 | 5,070 | 10,140 | 12,400 | 10,040 |
| TOTAL | $27,440 | $5,070 | $45,280 | $38,100 | $32,350 |
| Total Assets | $94,290 | $18,360 | $101,400 | $114,890 | $124,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 860 | 680 | 720 | 0 | 440 |
| Accounts payable and accrued liabilities | 6,360 | 5,760 | 8,560 | 9,700 | 11,490 |
| Accrued Expenses | 6,310 | 5,900 | 5,360 | 5,500 | 4,450 |
| Other current liabilities | 9,310 | 7,830 | 10,030 | 5,680 | 8,110 |
| TOTAL | $22,890 | $20,230 | $24,950 | $21,310 | $24,890 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,940 | N/A | 2,400 | 2,790 | 2,330 |
| Other Non-Current Liabilities | 17,490 | 20,490 | 19,030 | 17,430 | 9,830 |
| TOTAL | $26,520 | $20,780 | $21,800 | $20,540 | $12,790 |
| Total Liabilities | $49,430 | $41,010 | $46,770 | $41,860 | $37,690 |
| Shareholders' Equity | |||||
| Common Shares | 3,540 | 3,510 | 3,490 | 3,480 | 3,430 |
| Retained earnings | -171,640 | N/A | -148,120 | -110,380 | -75,180 |
| Other shareholders' equity | 14,470 | 12,150 | 14,080 | 6,450 | -2,720 |
| TOTAL | $44,860 | $208,740 | $54,620 | $73,020 | $86,650 |
| Total Liabilities And Equity | $94,290 | $249,750 | $101,390 | $114,880 | $124,340 |